Literature DB >> 17568802

Identification of novel pigmentation modulators by chemical genetic screening.

Li Ni-Komatsu1, Seth J Orlow.   

Abstract

There is a continual need for compounds that effectively modulate melanin synthesis. To identify novel pigmentation modulators and their cellular targets, chemical genetic screenings were performed with triazine-based combinatorial libraries that include various linkers as intrinsic components of the small molecules in the library. The linker provides a ready means of attachment to beads, eliminating several common time-consuming downstream steps in the isolation of cellular targets for the small molecules of interest. Twelve compounds were identified as novel pigmentation modulators from various screenings performed in normal and albino murine melanocytes and zebrafish. Target identification by affinity chromatography revealed unexpected roles for prohibitin and mitochondrial F1F0-adenotriphosphatase in the regulation of mammalian pigmentation. The identification of prohibitin, a "scaffold protein", as a propigmentation effector represents a novel mechanism by which propigmentary signals are transduced. Results from our screenings provide potential active agents and targets for the medical and aesthetic treatment of disorders of pigmentation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568802     DOI: 10.1038/sj.jid.5700852

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  A 3' UTR modification of the mitochondrial rieske iron sulfur protein in mice produces a specific skin pigmentation phenotype.

Authors:  Sofia Garcia; Francisca Diaz; Carlos T Moraes
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

2.  Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking.

Authors:  Li Ni-Komatsu; Chunxiang Tong; Guangming Chen; Nelya Brindzei; Seth J Orlow
Journal:  Mol Pharmacol       Date:  2008-09-18       Impact factor: 4.436

3.  Zebrafish as a model system to study skin biology and pathology.

Authors:  Qiaoli Li; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2014-06       Impact factor: 8.551

Review 4.  Small molecule screening in zebrafish.

Authors:  David S Peal; Randall T Peterson; David Milan
Journal:  J Cardiovasc Transl Res       Date:  2010-08-03       Impact factor: 4.132

Review 5.  The Zebrafish model in dermatology: an update for clinicians.

Authors:  Irene Russo; Emma Sartor; Laura Fagotto; Natascia Tiso; Mauro Alaibac; Anna Colombo
Journal:  Discov Oncol       Date:  2022-06-17

6.  Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads.

Authors:  Kerrie L Taylor; Nicola J Grant; Nicholas D Temperley; E Elizabeth Patton
Journal:  Cell Commun Signal       Date:  2010-06-12       Impact factor: 5.712

7.  A potent activator of melanogenesis identified from small-molecule screening.

Authors:  Brian R McNaughton; Peter C Gareiss; Stacey E Jacobs; Alex F Fricke; Glynis A Scott; Benjamin L Miller
Journal:  ChemMedChem       Date:  2009-10       Impact factor: 3.466

8.  A repressive role for prohibitin in estrogen signaling.

Authors:  Bin He; Qin Feng; Atish Mukherjee; David M Lonard; Francesco J DeMayo; Benita S Katzenellenbogen; John P Lydon; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2007-10-11

9.  Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesis.

Authors:  Hyoung Kyu Kim; Yong Kyu Kim; In-Sung Song; Sung-Ryul Lee; Seung Hun Jeong; Min Hee Kim; Dae Yun Seo; Nari Kim; Byoung Doo Rhee; Kyoung Soo Ko; Kwan Chul Tark; Chul Gyoo Park; Je-Yoel Cho; Jin Han
Journal:  Proteome Sci       Date:  2012-08-20       Impact factor: 2.480

10.  Isolation of 4,5-O-Dicaffeoylquinic Acid as a Pigmentation Inhibitor Occurring in Artemisia capillaris Thunberg and Its Validation In Vivo.

Authors:  Nadia Tabassum; Ji-Hyung Lee; Soon-Ho Yim; Galzad Javzan Batkhuu; Da-Woon Jung; Darren R Williams
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.